FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch
Executive SummaryDespite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public
You may also be interested in...
A new draft guidance explains the Center for Drug Evaluation and Research’s approach to communicating emerging drug safety information. Since 2010, Drug Safety Communications have replaced a variety of audience-focused tools laid out in a 2007 guidance, but FDA says public health alerts will be used to communicate about products that pose an immediate danger.